UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 136

Sortiert nach

Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma

The New England journal of medicine, 1993-12, Vol.329 (24), p.1770-1776

1993

Volltextzugriff (PDF)

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

European journal of cancer (1990), 2005, Vol.41 (2), p.225-230

2005

Volltextzugriff (PDF)

Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2

The Lancet (British edition), 1992-08, Vol.340 (8816), p.397-398

1992

Volltextzugriff (PDF)

The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma

Seminars in oncology, 1997-10, Vol.24 (5), p.561-571

Bramwell, V H

1997

Volltextzugriff (PDF)

Osteosarcomas and other cancers of bone

Current opinion in oncology, 2000-07, Vol.12 (4), p.330-336

Bramwell, Vivien H.C

2000

Volltextzugriff (PDF)

Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.513-513

2011

Volltextzugriff (PDF)

Prognostic and predictive impact of biologic classification by qRT-PCR with a 50-gene subtype predictor (PAM50) for adjuvant tamoxifen in premenopausal breast cancer: Results from the NCIC CTG MA.12 randomized trial

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.508-508

2010

Volltextzugriff (PDF)

Prognostic factors in adolescents and young adults (AYA) with high-risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on two pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.10573-10573

2009

Volltextzugriff (PDF)

Topoisomerase 11 Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

JNCI : Journal of the National Cancer Institute, 2009, Vol.101 (9), p.644-650

2009

Volltextzugriff (PDF)

The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): Pooled analysis of the two STBSG-EORTC phase III clinical trials

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.10525-10525

2008

Volltextzugriff (PDF)

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2651-2658

1998

Volltextzugriff (PDF)

Phase II intergroup study of sorafenib (S) in advanced soft tissue sarcomas (STS): SWOG 0505

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.10532-10532

2008

Volltextzugriff (PDF)

High-dose continuous venous infusion of interleukin-2 : influence of dose and infusion rate on tumoricidal function and lymphocyte subsets

Cancer Immunology Immunotherapy, 1995-09, Vol.41 (5), p.271-279

1995

Volltextzugriff (PDF)

P1-06-08: Effect of Treatment Emergent Symptoms on Relapse Free Survival: NCIC CTG MA.12 a Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women in Early Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-06-08

2011

Volltextzugriff (PDF)

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2302-2311

1997

Volltextzugriff (PDF)

Tamoxifen (T) compared to placebo (P), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC): Interim results of NCIC-CTG MA.12

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.547-547

2007

Volltextzugriff (PDF)

Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline

Sarcoma, 2000, Vol.2000 (3), p.103-112

2000

Volltextzugriff (PDF)

P2-12-28: Studies of a Malignancy-Associated Protein, Osteopontin, in NCIC CTG MA.14, a Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR in Adjuvant Treatment of Women with Early Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-12-28

2011

Volltextzugriff (PDF)

Adjuvant chemotherapy for soft tissue sarcomas

Cancer treatment and research, 1989, Vol.44, p.93

Bramwell, V H

1989

Volltextzugriff (PDF)

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer : A report of the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2302-2311

1997

Volltextzugriff (PDF)

Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.533-533

2006

Volltextzugriff (PDF)

Adjuvant chemotherapy of soft tissue sarcomas

Cancer treatment and research, 1993, Vol.67, p.117

1993

Volltextzugriff (PDF)

P5-14-01: Differences in Efficacy by Assessment Method: NCIC CTG Adjuvant Breast Cancer Trials MA.5, MA.12, MA.14, MA.21, MA.27 Meta-Analysis

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-14-01

2011

Volltextzugriff (PDF)

Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study

Investigational new drugs, 1988-09, Vol.6 (3), p.207-210

1988

Volltextzugriff (PDF)

Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?

European journal of cancer (1990), 1999-11, Vol.35 (12), p.1625-1627

1999

Volltextzugriff (PDF)

26 – 50 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(136)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(97)
Science & Technology
(84)
Life Sciences & Biomedicine
(83)
Female
(69)
Biological And Medical Sciences
(56)
Oncology
(55)
Medical Sciences
(53)
Middle Aged
(53)
Adult
(51)
Pharmacology. Drug Treatments
(39)
Male
(34)
Antineoplastic Agents
(33)
Chemotherapy
(33)
Sarcoma - Drug Therapy
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Aged
(31)
Soft Tissue Neoplasms - Drug Therapy
(26)
Adolescent
(24)
Breast Neoplasms - Drug Therapy
(22)
Chemotherapy, Adjuvant
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study

Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2

The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma

Osteosarcomas and other cancers of bone

Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer

Prognostic and predictive impact of biologic classification by qRT-PCR with a 50-gene subtype predictor (PAM50) for adjuvant tamoxifen in premenopausal breast cancer: Results from the NCIC CTG MA.12 randomized trial

Prognostic factors in adolescents and young adults (AYA) with high-risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on two pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials

Topoisomerase 11 Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): Pooled analysis of the two STBSG-EORTC phase III clinical trials

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group

Phase II intergroup study of sorafenib (S) in advanced soft tissue sarcomas (STS): SWOG 0505

High-dose continuous venous infusion of interleukin-2 : influence of dose and infusion rate on tumoricidal function and lymphocyte subsets

P1-06-08: Effect of Treatment Emergent Symptoms on Relapse Free Survival: NCIC CTG MA.12 a Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women in Early Breast Cancer

Tamoxifen (T) compared to placebo (P), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC): Interim results of NCIC-CTG MA.12

Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline

P2-12-28: Studies of a Malignancy-Associated Protein, Osteopontin, in NCIC CTG MA.14, a Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR in Adjuvant Treatment of Women with Early Breast Cancer

Adjuvant chemotherapy for soft tissue sarcomas

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer : A report of the National Cancer Institute of Canada Clinical Trials Group

Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5)

Adjuvant chemotherapy of soft tissue sarcomas

P5-14-01: Differences in Efficacy by Assessment Method: NCIC CTG Adjuvant Breast Cancer Trials MA.5, MA.12, MA.14, MA.21, MA.27 Meta-Analysis

Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study

Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?

Suchergebnisse filtern